Kestra Advisory Services, LLC
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1830819
AUSTIN, TX
Position in LCTX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$43,998
-$2,339 QoQ
Shares Held
27,847
+0.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kestra Advisory Services, LLC holds $25,787,088 across 48 Biotechnology names. LCTX ranks #41 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,950 | $6,229,233 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,470 | $3,453,700 | |
| 3 | CELC |
Celcuity Inc.
|
13,604 | $1,552,760 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
21,052 | $1,001,443 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
39,901 | $987,948 | |
| 6 | RPRX |
Royalty Pharma plc
|
18,736 | $898,765 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
27,122 | $882,549 | |
| 8 | CING |
Cingulate Inc.
|
140,000 | $869,400 |
All Filings in LCTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,998 | 27,847 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $46,337 | 27,747 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,069 | 10,100 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||